UPDATE : Tuesday, March 20, 2018
AstraZeneca’s ovarian cancer drug more affordable
AstraZeneca Korea said Friday its ovarian cancer drug Lynparza began to rec...
by Marian Chu  |  2017-10-11 18:14
Boryung to sell antihypertensive drugs in SE Asia
South Korea’s Boryung Pharmaceutical said it would sell its antihypertensiv...
by Lee Hye-seon  |  2017-10-11 16:02
Daewoong to sell Novartis’ osteoporosis drug
Daewoong pharmaceutical said Wednesday it acquired marketing and commercial...
by Marian Chu  |  2017-10-11 11:39
Green Cross units sign MOU with Sudan Central Lab
Green Cross MS and Green Cross Laboratories have signed a memorandum of und...
by Lee Han-soo  |  2017-10-10 15:53
SK Chemicals ‘Skyzoster’ wins sales approval
SK Chemicals received the sales approval for Skyzoster, a shingles vaccine,...
by Lee Han-soo  |  2017-10-10 12:16
Immunotherapy developers engage in fierce competition to expand indications
Bristol-Myers Squibb and Merck & Co are conducting several clinical trials ...
by Marian Chu  |  2017-10-05 06:00
Dongkook Pharm, Madagascar government to develop natural medicines
Dongkook Pharmaceuticals said Friday that it has signed an agreement with t...
by Lee Han-soo  |  2017-09-29 17:39
AbbVie’s hepatitis C treatment approved in Japan
AbbVie said Thursday that its G/P (glecaprevir/pibrentasivr) treatment, sho...
by Marian Chu  |  2017-09-29 12:03
Korea lags behind osteoporosis prevention and treatment
Osteoporosis prevention and treatment has been rather overlooked in Korea, ...
by Marian Chu  |  2017-09-29 10:21
World’s best-selling drug Humira gains insurance coverage in Korea
AbbVie Korea said Thursday its blockbuster biologic Humira gained nationwid...
by Marian Chu  |  2017-09-28 19:02
Amgen Korea’s osteoporosis treatment gets insurance coverage
Amgen Korea said Thursday its “first and only” biologic treatment for osteo...
by Marian Chu  |  2017-09-28 19:02
Korean drugmakers’ smart factories at ‘base level’
An increasing number of Korean pharmaceutical firms have built smart factor...
by Nam Doo-hyun  |  2017-09-28 16:00
Drugmakers need to differentiate big data from ‘large data’
It is necessary for Korean pharmaceutical companies to distinguish big data...
by Nam Doo-hyun  |  2017-09-27 17:44
Exelixis’ kidney cancer drug gains approval in Korea
The Ministry of Food and Drug Safety approved Friday Exelixis’ kidney drug ...
by Marian Chu  |  2017-09-27 17:44
Korean combos, incrementally modified drugs to get insurance benefits
Korean combination drugs for hypertension, diabetes, and hyperlipidemia, an...
by Lee Hye-seon  |  2017-09-27 11:29
Ilyang presents leukemia treatment’s clinical results
Ilyang Pharmaceuticals Tuesday released its phase 3 clinical trial result o...
by Lee Han-soo  |  2017-09-26 17:31
Ministry changes dosage recommendation for Bayer’s blood-thinning drug
The Ministry of Food and Drug Safety said Friday it has revised dosage reco...
by Marian Chu  |  2017-09-26 16:24
‘Keytruda will beat Opdivo in US because of biomarker’
"Opdivo had gone ahead of Keytruda in America until last year, but Keytruda...
by Nam Doo-hyun  |  2017-09-26 15:57
Pfizer launches ‘V-Rep’ for doctors helping smokers quit
Pfizer said Tuesday it has launched a “V-Rep” system, which provides custom...
by Marian Chu  |  2017-09-26 13:30
Sanofi Genzyme to launch metastatic colorectal cancer drug in Korea
Sanofi Genzyme said Tuesday it would launch its metastatic colorectal cance...
by Marian Chu  |  2017-09-26 11:07
Back to Top